FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics, namely to a non-aqueous preparation for external use, having a stimulating effect α2 adrenergic receptor. Non-aqueous preparation for external use, having an effect of stimulating α2 adrenergic receptor containing dexmedetomidine or its salt, from 0.5 wt.% to 10 wt.% of an aliphatic alcohol containing from 10 to 12 carbon atoms, from 1 wt.% to 12 wt.% of a propylene glycol monoester of a fatty acid containing from 8 to 14 carbon atoms, from 0.1 wt.% to 5 wt.% of an organic acid selected from one, two or more types of C2-C5 monocarboxylic acid, C2-C8 dicarboxylic acid, C2-C8 hydroxycarboxylic acid, C4-C8 ketocarboxylic acid and C6-C24 fatty acid, and from 0.05 wt.% to 5 wt.% of a salt of an organic acid selected from one, two or more types of salt of C2-C5 monocarboxylic acid, salts of C2-C8 dicarboxylic acid, salts of C2-C8 hydroxycarboxylic acid and salts of C4-C8 ketocarboxylic acid.
EFFECT: said invention inhibits deposition of dexmedetomidine crystals in the preparation and has satisfactory transdermal absorbability.
5 cl, 3 tbl, 9 ex, 11 com ex
Title | Year | Author | Number |
---|---|---|---|
RUPATADINE-CONTAINING PATCH | 2018 |
|
RU2776063C2 |
NEW SALT OF CONDENSED PYRIMIDINE COMPOUND AND CRYSTAL THEREOF | 2016 |
|
RU2702660C2 |
TRANSDERMALLY ABSORBABLE MEDICINAL PRODUCT | 2011 |
|
RU2576612C2 |
PHARMACEUTICAL COMPOSITION INCLUDING SODIUM ALKYL SULPHATE | 2019 |
|
RU2759746C1 |
TRANSCUTANEOUS SUCTION COMPOSITION | 2016 |
|
RU2702356C2 |
TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
PROLONGED RELEASE PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2704813C2 |
ANTISEPTIC, INCLUDING MEGLUMINE OR ITS SALT | 2017 |
|
RU2745617C2 |
LOXOPROFEN-CONTAINING PREPARATION FOR TOPICAL USE | 1997 |
|
RU2173145C2 |
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS | 2016 |
|
RU2723590C2 |
Authors
Dates
2024-03-01—Published
2020-05-26—Filed